Onset and duration of action of formoterol and tiotropium in patients with moderate COPD

被引：0
|
作者：
Richter, K
Stenglein, S
Muecke, M
Riedinger, F
Sieder, C
Schmidtmann, S
Harnest, U
Magnussen, H
机构：
[1] Pulm Res Inst, Grosshansdorf, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
[3] Pulmol Praxis, Berlin, Germany
来源：
THORAX | 2003年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [1] Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD
    Richter, Kai
    Stenglein, Stephan
    Mueck, Marion
    Sieder, Christian
    Schmidtmann, Soeren
    Harnest, Ulf
    Weidinger, Gottfried
    Magnussen, Helgo
    RESPIRATION, 2006, 73 (04) : 414 - 419
  • [2] ECONOMIC EVALUATION OF INDACATEROL VERSUS TIOTROPIUM OR FORMOTEROL FOR PATIENTS WITH MODERATE TO SEVERE COPD IN GREECE
    Geitona, M.
    Hatzikou, M.
    Bania, E.
    VALUE IN HEALTH, 2011, 14 (07) : A493 - A493
  • [3] Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients
    Cazzola, M
    Noschese, P
    Salzillo, A
    De Giglio, C
    D'Amato, G
    Matera, MG
    RESPIRATORY MEDICINE, 2005, 99 (05) : 524 - 528
  • [4] Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD
    Terzano, Claudio
    Petroianni, Angelo
    Conti, Vittoria
    Ceccarelli, Daniela
    Graziani, Elda
    Sanduzzi, Alessandro
    D'Avelli, Serena
    RESPIRATORY MEDICINE, 2008, 102 (12) : 1701 - 1707
  • [5] Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD
    Cazzola, M
    Santus, P
    Di Marco, F
    Carlucci, P
    Mondoni, M
    Matera, MG
    Centanni, S
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2004, 17 (03) : 121 - 125
  • [6] Onset of action of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in patients with COPD
    Cazzola, Mario
    Ora, Josuel
    Di Paolo, Alessanda
    Puxeddu, Ermanno
    Calzetta, Luigino
    Rogliani, Paola
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2016, 39 : 48 - 53
  • [7] Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD A randomised, multicentre, crossover trial
    Watz, Henrik
    Mailaender, Claudia
    May, Christoph
    Baier, Monika
    Kirsten, Anne-Marie
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 42 : 13 - 20
  • [8] Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD
    Rabe, Klaus F.
    Timmer, Wolfgang
    Sagkriotis, Alexandros
    Viel, Klaus
    CHEST, 2008, 134 (02) : 255 - 262
  • [9] Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD
    Tashkin, Donald P.
    Pearle, James
    Iezzoni, Domenic
    Varghese, Santosh T.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2009, 6 (01) : 17 - 25
  • [10] Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD
    Meyer, Thomas
    Reitmeir, Peter
    Brand, Peter
    Herpich, Christiane
    Sommerer, Knut
    Schulze, Anja
    Scheuch, Gerhard
    Newman, Stephen
    RESPIRATORY MEDICINE, 2011, 105 (06) : 900 - 906
12345